Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SILO is 4.29M, and currently, shorts hold a 6.34% of that float. The average trading volume for SILO on December 26, 2024 was 285.41K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SILO) stock’s latest price update
SILO Pharma Inc (NASDAQ: SILO)’s stock price has gone rise by 8.51 in comparison to its previous close of 0.88, however, the company has experienced a -5.22% decrease in its stock price over the last five trading days. globenewswire.com reported 2024-12-18 that Key preclinical milestone for novel, non-opioid extended-release pain therapeutic SARASOTA, FL, Dec. 18, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced the initiation of a pharmacokinetic (PK) and tolerability study in partnership with its contract research organization (CRO), AmplifyBio. The study is designed to assess the pharmacokinetics of Silo’s dissolvable ketamine-based injectable implant, SP-26, in a minipig model.
SILO’s Market Performance
SILO’s stock has fallen by -5.22% in the past week, with a monthly rise of 6.99% and a quarterly drop of -12.37%. The volatility ratio for the week is 9.31% while the volatility levels for the last 30 days are 11.25% for SILO Pharma Inc The simple moving average for the past 20 days is 4.24% for SILO’s stock, with a -32.53% simple moving average for the past 200 days.
SILO Trading at -7.66% from the 50-Day Moving Average
After a stumble in the market that brought SILO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.70% of loss for the given period.
Volatility was left at 11.25%, however, over the last 30 days, the volatility rate increased by 9.31%, as shares surge +10.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.09% lower at present.
During the last 5 trading sessions, SILO fell by -1.26%, which changed the moving average for the period of 200-days by -41.90% in comparison to the 20-day moving average, which settled at $0.9214. In addition, SILO Pharma Inc saw -36.10% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SILO starting from Weisblum Eric, who purchase 2,500 shares at the price of $0.84 back on Dec 13 ’24. After this action, Weisblum Eric now owns 187,932 shares of SILO Pharma Inc, valued at $2,097 using the latest closing price.
Weisblum Eric, the CEO and President of SILO Pharma Inc, purchase 2,500 shares at $0.95 during a trade that took place back on Nov 20 ’24, which means that Weisblum Eric is holding 182,932 shares at $2,375 based on the most recent closing price.
Stock Fundamentals for SILO
Current profitability levels for the company are sitting at:
- -56.25 for the present operating margin
- -3.72 for the gross margin
The net margin for SILO Pharma Inc stands at -52.47. The total capital return value is set at -0.54. Equity return is now at value -52.02, with -42.31 for asset returns.
Currently, EBITDA for the company is -3.63 million with net debt to EBITDA at 1.31. When we switch over and look at the enterprise to sales, we see a ratio of -7.8. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.91.
Conclusion
In conclusion, SILO Pharma Inc (SILO) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
